Bumper Offer - Urjas oil Just @ Rs. 1
Ramistar, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of High BP. Ramistar also has some secondary and off-label uses. These are listed below.
The optimal dosage of Ramistar is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Ramistar also has some side effects, the most common being Confusion. Apart from the aforementioned side effects, Ramistar can also lead to other problems, which have been listed below. Normally, these side effects of Ramistar are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Ramistar is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Ramistar related warnings talks about Ramistar's effects on the liver, heart and kidney.
Ramistar is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema, Heart Failure, Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Ramistar have been discussed in the sections ahead.
Additionally, Ramistar may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Ramistar, it is important to know that it is not safe while driving, and is not habit-forming.
Ramistar is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Ramistar is used -
Mild
Common
Is the use of Ramistar safe for pregnant women?
Ramistar should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ramistar safe during breastfeeding?
Ramistar may have very limited harmful effects for breastfeeding women.
What is the effect of Ramistar on the Kidneys?
Ramistar rarely affects the kidneys.
What is the effect of Ramistar on the Liver?
Ramistar has very mild side effects on the liver.
What is the effect of Ramistar on the Heart?
Ramistar may have mild side effects on the heart. Most people will never see any effect on the heart.
Ramistar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramistar unless your doctor advises you to do so -
Is this Ramistar habit forming or addictive?
Ramistar does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ramistar can make you feel drowsy.
Is it safe?
Ramistar should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Ramistar in mental disorders is not effective.
Interaction between Food and Ramistar
Taking Ramistar with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ramistar
It is difficult to say anything about the effect of Ramistar and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503